Gene Therapy Protocol Linked To Death Was Altered At FDA - RAC's Walters
Executive Summary
The gene therapy protocol implicated in the September death of an Arizona patient was modified during FDA review after the study was approved by the NIH Recombinant DNA Advisory Committee, panel members who evaulated the trial assert.